Enterprise AI startup Lyzr says its own agent, Agent Sam, fielded 130-plus investors while it raised a $100mn Series B at a roughly $500mn valuation.

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

And in Indianapolis, a city councillor who had voted to expand AI infrastructure woke to thirteen gunshots fired into his ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In Q2, Europe posted its strongest quarter in four years for venture funding, Crunchbase data shows. All told, Europe-based ...

Vitalik Buterin has published an updated long-term roadmap for Ethereum, calling the multi-year effort “Lean Ethereum” as the network’s biggest redesign since the Merge. He posted it to X on July 4, ...

Ethereum (ETH) surges 10% on organic buying with flat leverage. ETFs see inflows while Vitalik Buterin reveals Lean Ethereum ...

This week, Andrew Charlton, the federal assistant minister for science and technology, issued a stark warning about artificial intelligence (AI). Speaking at the AI Safety Forum at the University of ...

Vitalik Buterin's Lean Ethereum roadmap for 2026-2029 emphasizes quantum safety and privacy upgrades, though critics doubt ...